That's the scope of the authorized investigatory use in the US, so unless you think the Trump Administration is simultaneously promoting and sabotaging it, I think it's the intended target:
“VEKLURY® (remdesivir) is authorized for use under an EUA only for the treatment of adult and pediatric patients hospitalized with suspected or laboratory-confirmed COVID-19, and for whom use of an intravenous (IV) agent is clinically appropriate. VEKLURY must be administered via IV infusion.”
https://www.remdesivir.com/us/?gclsrc=aw.ds&&gclid=CjwKCAjwi...